CORONA Remedies Limited has scheduled a series of investor meetings as part of a Non-Deal Roadshow (NDR) on June 4 and June 5, 2026. The meetings, organized by JM Financial, will provide an opportunity for investors to engage with company officials in Mumbai. The discussions will focus on publicly available information, ensuring no unpublished price sensitive information (UPSI) is disclosed during the sessions.

The regulatory disclosure was made pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company noted that the schedule is subject to change due to exigencies on the part of the host or the company.

The following table outlines the schedule for the investor meetings:

The intimation regarding these meetings has been made available on the company's official website.

Ankur Mehta, Joint Managing Director and Promoter of corona remedies , has declared that no encumbrance has been made on the equity shares held by him or Persons Acting in Concert (PACs) during the financial year 2025-2026. The disclosure, submitted to the stock exchanges, confirms that neither the promoter nor the identified PACs have encumbered any equity shares of the company, whether held directly or indirectly, throughout the specified financial period. This filing was made under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

The declaration was addressed to the Department of Corporate Relations at BSE Limited and the Department of Corporate Services at the National Stock Exchange of India Limited. A copy was also forwarded to the Audit Committee and the Company Secretary and Compliance Officer of CORONA Remedies Limited for their records.

Persons Acting in Concert

The disclosure includes an annexure listing the individuals and entities classified as PACs, categorized under Promoter and Promoter Group. The list comprises family members and associated entities of the promoter.